Vera Therapeutics Stock Analysis

Vera Stock Analysis Notes

About 97.0% of the company outstanding shares are owned by institutional investors. The book value of Vera Therapeutics was at this time reported as 2.78. The company recorded a loss per share of 2.86. Vera Therapeutics had not issued any dividends in recent years. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. Vera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people. For more information please call the company at 650 770 0077 or visit https://veratx.com.

Vera Therapeutics Investment Alerts

Vera Therapeutics Upcoming and Recent Events

Vera Largest EPS Surprises

View All Earnings Estimates

Vera Therapeutics SEC Filings

Vera Therapeutics Thematic Classifications

Vera Stock Institutional Investors

Note, although Vera Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vera Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 571.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vera Therapeutics's market, we take the total number of its shares issued and multiply it by Vera Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Vera Profitablity

Management Efficiency

Vera Therapeutics has return on total asset (ROA) of (0.4421) % which means that it has lost $0.4421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8959) %, meaning that it created substantial loss on money invested by shareholders. Vera Therapeutics' management efficiency ratios could be used to measure how well Vera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2023, Return on Average Assets is expected to decline to -0.67. In addition to that, Return on Average Equity is expected to decline to -0.83. At present, Vera Therapeutics' Assets Non Current are projected to increase significantly based on the last few years of reporting. The current year's Tangible Assets Book Value per Share is expected to grow to 5.08, whereas Total Assets are forecasted to decline to about 109 M.

Technical Drivers

As of the 28th of November, Vera Therapeutics has the Coefficient Of Variation of (1,446), variance of 20.06, and Risk Adjusted Performance of (0.045517). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vera Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Vera Therapeutics, which can be compared to its competition. Please validate Vera Therapeutics market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Vera Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 12.94 per share. Given that Vera Therapeutics has information ratio of (0.08), we advise you to double-check Vera Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Vera Therapeutics Price Movement Analysis

Vera Therapeutics Insider Trading Activities

Vera Therapeutics Predictive Daily Indicators

Vera Therapeutics Forecast Models

Vera Therapeutics' time-series forecasting models are one of many Vera Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vera Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vera Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vera shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Vera Therapeutics. By using and applying Vera Stock analysis, traders can create a robust methodology for identifying Vera entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vera analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vera analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Vera Therapeutics stock analysis indicators help investors evaluate how Vera Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vera Therapeutics shares will generate the highest return on investment. By understating and applying Vera Therapeutics stock analysis, traders can identify Vera Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vera Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Vera Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vera Therapeutics. If investors know Vera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vera Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Vera Therapeutics is measured differently than its book value, which is the value of Vera that is recorded on the company's balance sheet. Investors also form their own opinion of Vera Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vera Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vera Therapeutics' market value can be influenced by many factors that don't directly affect Vera Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vera Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vera Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vera Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.